Day: May 29, 2025

Cost Discrepancy of Rifaximin: Factors Contributing to the 95% Surge in Price in the U.S. Relative to Asia

Cost Discrepancy of Rifaximin: Factors Contributing to the 95% Surge in Price in the U.S. Relative to AsiaCost Discrepancy of Rifaximin: Factors Contributing to the 95% Surge in Price in the U.S. Relative to Asia

Rifaximin: Exploring Global Pricing Inequities and Access Obstacles Rifaximin, an antibiotic with minimal absorption, is an essential treatment for various gastrointestinal disorders, including irritable bowel syndrome with diarrhea (IBS-D) and